Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Carvedilol 6.25mg tablets
020400080AAAFAF
|
Carvedilol | Carvedilol | Cardiovascular System | 59,156 |
|
Carvedilol 3.125mg tablets
020400080AAAEAE
|
Carvedilol | Carvedilol | Cardiovascular System | 49,417 |
|
Carvedilol 12.5mg tablets
020400080AAABAB
|
Carvedilol | Carvedilol | Cardiovascular System | 43,133 |
|
Carvedilol 25mg tablets
020400080AAACAC
|
Carvedilol | Carvedilol | Cardiovascular System | 31,997 |
|
Carvedilol 5mg/5ml oral suspension
020400080AAAPAP
|
Carvedilol | Carvedilol | Cardiovascular System | 377 |
|
Carvedilol 1.5mg/5ml oral suspension
020400080AAAMAM
|
Carvedilol | Carvedilol | Cardiovascular System | No data available |
|
Carvedilol 3.125mg/5ml oral suspension
020400080AAADAD
|
Carvedilol | Carvedilol | Cardiovascular System | No data available |
|
Carvedilol 3.5mg suppositories
020400080AAANAN
|
Carvedilol | Carvedilol | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.